Education
About Us
Working with TipRanks
Follow Us
Brendan B Springstubb Insider Profile
4 Followers
Brendan B Springstubb, Director at SunOpta, holds 58.82K shares in Evolent Health (Ticker: EVH), holds 97.39K shares in SunOpta (Ticker: STKL). Most recently, Brendan B Springstubb Bought ― shares of Evolent Health on Nov 19, 2025 for an estimated value of $38.10K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-33.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Brendan B Springstubb holds in companies
Most Profitable Insider Trade
The most profitable trade made by Brendan B Springstubb
Brendan B Springstubb's Trading History
SunOpta
Jun 16, 2020
Director
Uninformative Buy
109.11K
$374.96K
Evolent Health
Nov 19, 2025
Director
Informative Buy
38.10K
$231.75K
List of latest transactions for each holding click on a transaction to see Brendan B Springstubb's performance on stock
You May Also Like
Brendan B Springstubb insider profile FAQ
What is the percentage of profitable transactions made by Brendan B Springstubb?
The percentage of profitable transactions made by Brendan B Springstubb is 33%.
What is the average return per transaction made by Brendan B Springstubb?
The average return per transaction made by Brendan B Springstubb is -33.40%.
What stocks does Brendan B Springstubb hold?
Brendan B Springstubb holds: STKL, EVH stocks.
What was Brendan B Springstubb’s latest transaction?
Brendan B Springstubb latest transaction was an Informative Buy of $38.10K.
What was Brendan B Springstubb's most profitable transaction?
Brendan B Springstubb’s most profitable transaction was an Informative Buy of EVH stock on November 19, 2025. The return on the trade was 11.20%.
What is Brendan B Springstubb's role in SunOpta?
Brendan B Springstubb's role in SunOpta is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.